ClinicalTrials.gg
RecruitingNCT05898269PROLOADUpdated Jan 18, 2024

Fluid Responsiveness Prediction During Prone Position

An interventional study of Trendelenburg maneuver and End-expiratory occlusion test (EE OCC) in Acute Respiratory Distress Syndrome, sponsored by Hospices Civils de Lyon. Recruiting at 4 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-18.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon — 2 open to participants now, 2 under way, none of them phase 3. Respiratory Distress Syndrome · Hospices Civils de Lyon.

Planned enrollment
3rd of 13
96 · median 31
Started
2023
the only one that year
No phase
13 of 15
1 open now
Registered
14th of 15
by date

Among the 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon, this one is the 3rd largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2023, is one of 13 with no phase, and was the 14th registered.

Respiratory Distress Syndrome

1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.

Browse Respiratory Distress Syndrome studies →

Open to participants now

2 of the 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon, or all of them as a file.
02

Study summary

Predicting fluid responsiveness is primordial when caring for patients with circulatory shock as it allows correction of preload-dependent low cardiac output states, while preserving patients of the deleterious effects of excessive fluid resuscitation.

Patients with severe acute respiratory distress syndrome (ARDS) treated with prone positioning (PP) are a specific subset of patients, as 1) they frequently present with shock; 2) excessive fluid administration may lead to respiratory worsening due to increased hydrostatic oedema with potential subsequent worse clinical outcome; and 3) all available dynamic tests evaluating fluid responsiveness can only be performed in patients in the supine condition (which in the case of severe ARDS patients in PP occurs only for 8h over 24h). These elements warrant the development of specific tests allowing the clinician to predict fluid responsiveness with enough exactitude when caring for these patients.

We hypothesize that there exists diagnostic heterogeneity in the predictive performance of 4 clinical tests to identify fluid responsiveness in ARDS patients in PP. For the matter of this study, these 4 tests are the Trendelenburg maneuver, the end-expiratory occlusion test, the end-expiratory occlusion test associated with the end-inspiratory occlusion test, and the tidal volume challenge. The diagnostic reference of the study will be the relative change in cardiac index measured by transpulmonary thermodilution before and after a 500 ml fluid bolus, and will allow the adjudication of patients as being fluid responsive or not.

The primary objective of the study is to determine the area under the ROC curve of each of the 4 tests, with their respective 95% confidence interval.

All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. Patients will only participate once. The expected duration of study participation is 30 minutes maximum.

03

Conditions studied

  • Acute Respiratory Distress Syndrome

Keywords

  • Acute respiratory distress syndrome
  • Fluid responsiveness
  • Fluid resuscitation
  • Cardiac output
  • Cardiac preload
  • Prone position
  • Continuous cardiac output monitoring
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patient (including patient under protective measures/wardship)
  • with ARDS as defined by the Berlin criteria
  • in the prone position as per international guidelines
  • with a calibrated continuous cardiac output monitoring device
  • with a clinical indication for a fluid bolus as prescribed by the clinician in charge, and fulfilling at least 2 clinical criteria: mottles, tachycardia, hypotension, drop in cardiac output, oliguria, high arterial lactate concentration, or any other detailed criterion
  • with no respiratory efforts

Exclusion criteria

Exclusion Criteria:

  • acute cor pulmonale
  • patient treated with veno-venous extra-corporeal membrane oxygenation
  • hemorrhagic shock
  • C cirrhosis
  • death expected to occur in less than 24h
  • decision to withhold or suspend active treatments
  • intracranial hypertension
  • lower limb amputation
  • obstruction of the inferior vena cava
  • acute abdominal syndrome
  • absence of consent to participate
  • pregnancy
  • patient previously enrolled in the same study
  • lack of affiliation to a social security regimen, as per French legislation
  • patient deprived of its liberty
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    Trendelenburg maneuver-EE OCC-EI OCC-Tidal volume challenge

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Trendelenburg maneuver-EE OCC-Tidal volume challenge-EI OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Trendelenburg maneuver-Tidal volume challenge-EI OCC-EE OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Trendelenburg maneuver-Tidal volume challenge-EE OCC-EI OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Trendelenburg maneuver-EI OCC-Tidal volume challenge-EE OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Trendelenburg maneuver-EI OCC-EE OCC-Tidal volume challenge

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EE OCC-EI OCC-Tidal volume challenge-Trendelenburg maneuver

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EE OCC-EI OCC-Trendelenburg maneuver-Tidal volume challenge

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EE OCC-Tidal volume challenge-Trendelenburg maneuver-EI OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EE OCC-Tidal volume challenge-EI OCC-Trendelenburg maneuver

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EE OCC-Trendelenburg maneuver-Tidal volume challenge-EI OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EE OCC-Trendelenburg maneuver-EI OCC-Tidal volume challenge

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EI OCC-Tidal volume challenge-EE OCC-Trendelenburg maneuver

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EI OCC-Tidal volume challenge-Trendelenburg maneuver-EE OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EI OCC-Trendelenburg maneuver-EE OCC-Tidal volume challenge

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EI OCC-Trendelenburg maneuver-Tidal volume challenge-EE OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EI OCC-EE OCC-Trendelenburg maneuver-Tidal volume challenge

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    EI OCC-EE OCC-Tidal volume challenge-Trendelenburg maneuver

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Tidal volume challenge-EI OCC-EE OCC-Trendelenburg maneuver

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Tidal volume challenge-EI OCC-Trendelenburg maneuver-EE OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Tidal volume challenge-Trendelenburg maneuver-EE OCC- EI OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Tidal volume challenge-Trendelenburg maneuver- EI OCC-EE OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Tidal volume challenge-EE OCC-Trendelenburg maneuver- EI OCC

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

  • Experimental
    Tidal volume challenge-EE OCC- EI OCC-Trendelenburg maneuver

    All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence

    Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)

Interventions

  • Diagnostic testTrendelenburg maneuver

    Bed tilting from the +13° position to the -13° position for 60 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the highest value observed during the maneuver

  • Diagnostic testEnd-expiratory occlusion test (EE OCC)

    End-expiratory pause performed on the ventilator, and maintained for 15 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the value observed in the last 5 seconds of the respiratory pause

  • Diagnostic testEnd-expiratory and end-inspiratory occlusion test (EI OCC)

    End-inspiratory pause performed on the ventilator, and maintained for 15 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the value observed in the last 5 seconds of the respiratory pause. The evaluator is calculated as the sum of the relative change in cardiac index observed during the end-expiratory pause and that of the end-inspiratory pause. Hence, for this test, the evaluator will be coupled with that of intervention 2 (end-expiratory occlusion test).

  • Diagnostic testTidal volume challenge

    Increase in tidal volume set on the ventilator from 6 ml.kg-1 of predicted body weight, to 8 ml.kg-1 for 60 seconds. Evaluator: difference in the pulse pressure variation measured at 6 ml.kg-1 and at 8 ml.kg-1.

  • Diagnostic testFluid bolus (reference diagnostic method)

    After the 4 tests, the patient will receive a 500-ml fluid bolus of crystalloids in less than 15 minutes. Evaluator (reference method): cardiac index measured by transpulmonary thermodilution before and immediately after the fluid bolus. Patients with a relative change in cardiac index \> 15% will be identified as being fluid responders, and the others as non-responders.

06

What researchers measure

Primary outcomes

  1. Area under the ROC curve (AUROC) of the evaluated tests.

    The AUROC will be determined for each of the 4 clinical tests evaluated in this study. The reference method to define the AUROC to design the curve will be the fluid responsive status (responder vs. non-responder) as determined by the fluid bolus. For each test, the AUROC will be accompanied with its 95% confidence interval.

    Time frame: 30 minutes

Secondary outcomes

  1. Comparison of diagnostic performance of the evaluated tests.

    For this outcome measure, the AUROCs will be determined as for the primary outcome measure. The AUROCs will be compared using the Delong's method, with adjustments for the repetition of measurements in a single patient.

    Time frame: 30 minutes

  2. Diagnostic performance metrics of each test

    Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of the evaluated tests, computed for the optimal diagnostic threshold determined using the Youden J index of the ROC curve. The optimal threshold will only be computed for AUROCs significantly different from 0.5.

    Time frame: 30 minutes

  3. Weighted diagnostic performance of each test

    Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of the evaluated tests, computed for the optimal diagnostic threshold determined using the Youden J index of the ROC curve, and adjusted using weighting based on the clinical tradeoff of the subsequent fluid bolus on hemodynamic benefit vs. the respiratory risk. The optimal threshold will only be computed for AUROCs significantly different from 0.5.

    Time frame: 30 minutes

  4. Grey zone area of the optimal diagnostic threshold of each test

    Determination of the boundaries of a grey zone around the value of the optimal threshold of each test, in which the diagnostic performance is deemed clinically insufficient (excessive misclassification risk due to lack of discrimination). The grey zone around the optimal threshold will only be computed for AUROCs significantly different from 0.5.

    Time frame: 30 minutes

07

Study locations

1 of 4 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Oct 2026, 36 months after the start.

Of 266 non-industry interventional studies with no phase under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 36 months is above that.

Counting every sponsor, half of 273 studies reached it within 24 months; a quarter within 12 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2023
First posted
Jun 12, 2023
StartActual
Oct 6, 2023
Primary completionEst.
Oct 2026
CompletionEst.
Oct 2026
Last update
Jan 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05898269
Responsible party
Sponsor
First posted
Jun 12, 2023
Start date
Oct 6, 2023
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Jan 18, 2024

Study contacts

Laurent BITKER, Dr
Contact
laurent.bitker@chu-lyon.fr
4 26 10 94 93 ext. +33
Mathieu Jozwiak, Dr
Contact
4 92 03 55 10 ext. +33
Hodane YONIS, Dr
principal investigator · Hospices Civils de Lyon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion